Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

0.49
BATS BZX Real-Time Price
As of 3:57pm ET
 -0.0197 / -3.87%
Today’s Change
0.41
Today|||52-Week Range
2.24
-23.04%
Year-to-Date
No recent news for MannKind Corp.

Today’s Trading

Previous close0.51
Today’s open0.51
Day’s range0.48 - 0.51
Volume89,314
Average volume (3 months)4,899,128
Market cap$244.0M
Dividend yield--
Data as of 3:57pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+112.64%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IDRAIdera Pharmaceutical...+0.01+0.60%
PETXAratana Therapeutics...-0.03-0.46%
TTPHTetraphase Pharmaceu...+0.03+0.58%
TGTXTG Therapeutics Inc+0.50+10.64%
Data as of 3:57pm ET, 02/22/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts


Search for Jobs